Tri Locum Partners LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Tri Locum Partners LP held in its portfolio 15 assets valued at $770,122,933 (i.e. $770.12M).

The most valuable assets in the portfolio included: JOHNSON & JOHNSON ($124.82M), DANAHER CORPORATION ($79.41M), and ELI LILLY & CO ($68.01M).

The chart below shows the top 10 valuable assets, and the table below shows the top 15 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Tri Locum Partners LP Portfolio

JOHNSON & JOHNSON

DANAHER CORPORATION

ELI LILLY & CO

UNITED THERAPEUTICS CORP DEL

ASCENDIS PHARMA A/S

MADRIGAL PHARMACEUTICALS INC

BOSTON SCIENTIFIC CORP

TEVA PHARMACEUTICAL INDS LTD

IONIS PHARMACEUTICALS INC

VERA THERAPEUTICS INC

Tri Locum Partners LP - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
JOHNSON & JOHNSON	603143	124820444	COM
DANAHER CORPORATION	346875	79406625	COM
ELI LILLY & CO	63284	68010049	COM
UNITED THERAPEUTICS CORP DEL	120921	58918757	COM
ASCENDIS PHARMA A/S	265015	56511799	SPONSORED ADR
MADRIGAL PHARMACEUTICALS INC	86023	50094634	COM
BOSTON SCIENTIFIC CORP	520508	49630438	COM
TEVA PHARMACEUTICAL INDS LTD	1435865	44813347	SPONSORED ADS
IONIS PHARMACEUTICALS INC	557174	44078035	COM
VERA THERAPEUTICS INC	805689	40800091	CL A
AXSOME THERAPEUTICS INC	201627	36825155	COM
ARGENX SE	37653	31664290	SPONSORED ADR
NUVALENT INC	307371	30918449	COM
DEXCOM INC	421600	27981592	COM
DIANTHUS THERAPEUTICS INC	622403	25649228	COM